IOBCF Quote, Financials, Valuation and Earnings

Galapagos NV has a net margin of -- compared to Ion Beam Applications SA's net margin of -286.67%. Ion Beam Applications SA's return on equity of 8.22% beat Galapagos NV's return on equity of -16.48%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Galapagos NV has an analysts' consensus of $27.63 which suggests that it could fall by -16.56%. Given that Galapagos NV has higher upside potential than Ion Beam Applications SA, analysts believe Galapagos NV is more attractive than Ion Beam Applications SA.

Ion Beam Applications SA has a beta of 1.124, which suggesting that the stock is 12.39% more volatile than S&P 500. In comparison Galapagos NV has a beta of 0.185, suggesting its less volatile than the S&P 500 by 81.495%.

Ion Beam Applications SA has a quarterly dividend of $0.28 per share corresponding to a yield of 1.88%. Galapagos NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays 53.12% of its earnings as a dividend. Galapagos NV pays out -- of its earnings as a dividend. Ion Beam Applications SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than Galapagos NV quarterly revenues of $83.2M. Ion Beam Applications SA's net income of -- is lower than Galapagos NV's net income of -$238.4M. Notably, Ion Beam Applications SA's price-to-earnings ratio is 23.52x while Galapagos NV's PE ratio is 21.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.67x versus 6.89x for Galapagos NV. Usually stocks with elevated PS ratios are considered overvalued.

MDxHealth SA has a net margin of -- compared to Ion Beam Applications SA's net margin of -29.2%. Ion Beam Applications SA's return on equity of 8.22% beat MDxHealth SA's return on equity of -548.42%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand MDxHealth SA has an analysts' consensus of $7.0400 which suggests that it could grow by 110.15%. Given that MDxHealth SA has higher upside potential than Ion Beam Applications SA, analysts believe MDxHealth SA is more attractive than Ion Beam Applications SA.

Ion Beam Applications SA has a beta of 1.124, which suggesting that the stock is 12.39% more volatile than S&P 500. In comparison MDxHealth SA has a beta of -557,066.812, suggesting its less volatile than the S&P 500 by 55706781.163%.

Ion Beam Applications SA has a quarterly dividend of $0.28 per share corresponding to a yield of 1.88%. MDxHealth SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays 53.12% of its earnings as a dividend. MDxHealth SA pays out -- of its earnings as a dividend. Ion Beam Applications SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than MDxHealth SA quarterly revenues of $27.4M. Ion Beam Applications SA's net income of -- is lower than MDxHealth SA's net income of -$8M. Notably, Ion Beam Applications SA's price-to-earnings ratio is 23.52x while MDxHealth SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.67x versus 1.60x for MDxHealth SA. Usually stocks with elevated PS ratios are considered overvalued.

Nyxoah SA has a net margin of -- compared to Ion Beam Applications SA's net margin of -1195.73%. Ion Beam Applications SA's return on equity of 8.22% beat Nyxoah SA's return on equity of -96.48%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Nyxoah SA has an analysts' consensus of $11.23 which suggests that it could grow by 136.34%. Given that Nyxoah SA has higher upside potential than Ion Beam Applications SA, analysts believe Nyxoah SA is more attractive than Ion Beam Applications SA.

Ion Beam Applications SA has a beta of 1.124, which suggesting that the stock is 12.39% more volatile than S&P 500. In comparison Nyxoah SA has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Ion Beam Applications SA has a quarterly dividend of $0.28 per share corresponding to a yield of 1.88%. Nyxoah SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays 53.12% of its earnings as a dividend. Nyxoah SA pays out -- of its earnings as a dividend. Ion Beam Applications SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than Nyxoah SA quarterly revenues of $2.3M. Ion Beam Applications SA's net income of -- is lower than Nyxoah SA's net income of -$27.6M. Notably, Ion Beam Applications SA's price-to-earnings ratio is 23.52x while Nyxoah SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.67x versus 28.18x for Nyxoah SA. Usually stocks with elevated PS ratios are considered overvalued.

UCB SA has a net margin of -- compared to Ion Beam Applications SA's net margin of --. Ion Beam Applications SA's return on equity of 8.22% beat UCB SA's return on equity of 13.88%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand UCB SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Ion Beam Applications SA has higher upside potential than UCB SA, analysts believe Ion Beam Applications SA is more attractive than UCB SA.

Ion Beam Applications SA has a beta of 1.124, which suggesting that the stock is 12.39% more volatile than S&P 500. In comparison UCB SA has a beta of 0.675, suggesting its less volatile than the S&P 500 by 32.475%.

Ion Beam Applications SA has a quarterly dividend of $0.28 per share corresponding to a yield of 1.88%. UCB SA offers a yield of 0.57% to investors and pays a quarterly dividend of $0.79 per share. Ion Beam Applications SA pays 53.12% of its earnings as a dividend. UCB SA pays out 15.96% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than UCB SA quarterly revenues of --. Ion Beam Applications SA's net income of -- is lower than UCB SA's net income of --. Notably, Ion Beam Applications SA's price-to-earnings ratio is 23.52x while UCB SA's PE ratio is 37.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.67x versus 7.26x for UCB SA. Usually stocks with elevated PS ratios are considered overvalued.